The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.


Updates from The Motley Fool

Latest updates on AstraZeneca from Fool.com.  The Fool has written over 600 articles on AstraZeneca.
3 Value Stocks for Every Investor

Who doesn't like a good value? Here are several stocks that offer a little something for almost e...



Stock Performance

View Interactive AZN Charts
Sponsored by

Key Data Points

Primary metrics and data points about AstraZeneca.
Current Price: $29.12
Prev Close: $29.08
Open: $29.09
Bid: $28.95
Ask: $29.50
Day's Range: $28.88 - $29.16
52wk Range: $25.55 - $35.60
Volume: 4,184,892
Avg Vol 6,375,724
Market Cap: $74B
P/E (ttm): 13.04
EPS (ttm): $0.00
Div & Yield: $0.90 (4.7%)

Company Rating

What our community thinks about AstraZeneca.
CAPS Rating 4 out of 5
 
703 Outperform
42 Underperform
CAPS All Stars
 
146 Outperform
8 Underperform

How do you think AstraZeneca will perform against the market?



You pick for AstraZeneca is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Pascal Soriot, CEO

88% Approve

Based on 467 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AstraZeneca.

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers